The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials (Q36156898)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials (English)

1 reference

Europe PubMed Central

12 August 2017

United States of America

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

activated carbon

1 reference

based on heuristic

inferred from title

Giuseppe Remuzzi

object named as

Giuseppe Remuzzi

4

0 references

author name string

Gerald Schulman

1

1 reference

Europe PubMed Central

12 August 2017

Tomas Berl

2

1 reference

Europe PubMed Central

12 August 2017

Gerald J Beck

3

1 reference

Europe PubMed Central

12 August 2017

Eberhard Ritz

5

1 reference

Europe PubMed Central

12 August 2017

Miho Shimizu

6

1 reference

Europe PubMed Central

12 August 2017

Yuko Shobu

7

1 reference

Europe PubMed Central

12 August 2017

Mami Kikuchi

8

1 reference

Europe PubMed Central

12 August 2017

publication date

30 September 2016

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

17

1 reference

Europe PubMed Central

12 August 2017

141

1 reference

Europe PubMed Central

12 August 2017

1

1 reference

Europe PubMed Central

12 August 2017

Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 October 2017

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 October 2017

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 October 2017

AST-120 for the management of progression of chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 October 2017

Standards of medical care in diabetes--2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 October 2017

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 October 2017

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 October 2017

Low protein diets for chronic kidney disease in non diabetic adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 October 2017

Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 July 2018

Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

2 July 2018

Level of renal function in patients starting dialysis: an ERA-EDTA Registry study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

23 September 2018

Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

23 September 2018

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

23 September 2018

Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5045594

23 September 2018

2005 Annual Report: ESRD Clinical Performance Measures Project.

1 reference

https://api.crossref.org/works/10.1186%2FS12882-016-0357-9

21 January 2018

A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD

1 reference

https://pubmed.ncbi.nlm.nih.gov/27716149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/27716149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/27716149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/27716149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/27716149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The progressive cost of complications in type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/27716149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27716149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'

1 reference

https://pubmed.ncbi.nlm.nih.gov/27716149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12882-016-0357-9

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36156898&oldid=1984226904"